Board Member
UNITED THERAPEUTICS Corp (UTHR)Equibles does not estimate personal net worth.
Get an email with a short summary when UNITED THERAPEUTICS Corp publishes a filing, an earnings call transcript or a press release.
Get UTHR alertsMichael Benkowitz is recorded as COO and Board Member at UNITED THERAPEUTICS Corp (UTHR). The newest filing on record that lists Michael Benkowitz as Board Member at UNITED THERAPEUTICS Corp (UTHR) is dated April 29, 2022. The proxy statement of UNITED THERAPEUTICS Corp reports total compensation of $8,383,194 for Michael Benkowitz in fiscal 2019, including a base salary of $845,577. Disclosed compensation is on record for 3 fiscal years. Michael Benkowitz has spoken on 22 earnings calls across 1 company, most recently for UNITED THERAPEUTICS Corp on August 5, 2026. UNITED THERAPEUTICS Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at UNITED THERAPEUTICS Corp includes Christopher Causey (Board Member), Christopher Patusky (Board Member), James Edgemond (Board Member) and 7 others.
“For the second quarter of 2026, we generated approximately $783 million in total revenue, essentially flat with the first quarter.”
“That's a tough act to follow, but I'm going to do my best. Good morning, everyone. For the first quarter of 2026, we recorded $782 million in total revenue.”
“2025 marked another year of record-breaking revenue, driven by double-digit percent revenue growth from Typeso and Orinotram, leading to 11% total revenue growth over a full year of 2024 and surpassing $3 billion in total revenue for the first time in our history.”
“Today, we are pleased to report another quarter of record total revenues of $800 million, representing 7% growth from the third quarter of 2024.”
“Today we are pleased to report a strong start to the year with another quarter of record revenue at $794 million, representing 17% growth from the first quarter of 2024, driven by robust results for each of our treprostinil products.”
Start not stated–present
Last confirmed April 29, 2022
Drug Manufacturers - Specialty & Generic · Healthcare
COO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | UNITED THERAPEUTICS Corp (UTHR) | President and Chief Operating Officer | $845,577 | $8,383,194 |
| 2018 | UNITED THERAPEUTICS Corp (UTHR) | President and Chief Operating Officer | $833,333 | $6,609,258 |
| 2017 | UNITED THERAPEUTICS Corp (UTHR) | President and Chief Operating Officer | $733,333 | $6,517,529 |
